Please assess the completion status of the following clinical trial:

Trial Title: RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria~* Displaced 3- and 4-part proximal humerus fractures.~* Age greater than or equal to 65 years old.~Exclusion Criteria~* Less than 65 years old.~* Medical comorbidities precluding surgical treatment or anesthesia~* Dementia or inability to provide adequate follow up.~* Pathologic fractures~* Open fractures~* Associated injuries: fracture dislocations, multiple or complex injuries of the ipsilateral limb, complete brachial plexopathy, vascular injury and polytrauma.

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Nonoperative Treatment (Type: OTHER): Subjects will have nonoperative treatment to treat proximal humerus fracture that is broken into 3 or 4 parts.
- Operative Course for rTSA (Type: OTHER): Subjects will have shoulder replacement surgery to treat proximal humerus fracture that is broken into 3 or 4 parts.

Based on this trial design, predict the completion outcome and termination type (if applicable).